Monitoring of preventive treatment of children having latent tuberculosis infection
https://doi.org/10.34215/1609-1175-2021-2-43-46
Abstract
Objective: To estimate the effectiveness of preventive treatment for children having latent tuberculosis infection according to the dynamics of the recombinant tuberculosis allergen (RTA) test.
Methods: The retrospective analysis of the life anamnesis, epidemic anamnesis and the results of the helical computed tomography of the thoracic organs was carried out among 388 children from 2 to 17 years old with positive RTA test results who got preventive treatment course. The dynamics of the RTA test results were studied after one and two years of treatment.
Results: Screening using immunodiagnostics and the following helical computed tomography for children having positive results of the skin test allows to reveal latent tuberculosis infection and minimal post-tuberculous changes. Dense calcium up to 5 mm in lymph nodes and lungs were observed more often among children having hyperergic reaction on immunological test. After two years of preventive treatment among 30.9 % of children having normergic reaction on RTA the test conversion from positive to negative, and also the decrease of the average size of the of skin papules from 11.3 to 5.4 mm was observed. Among children having hyperergic results of the RTA test a decrease of the average size of the papules from 15.6 to 7.2 mm was observed after chemotherapy. Among this group the decrease in the number of hyperergic tests (down to 8.6 %) was registered two years after observation.
Conclusions: Annual monitoring of the RTA tests results can be used to estimate the effectiveness of preventive treatment of the latent tuberculosis infection among children and adolescents.
About the Authors
O. D. BaronovaRussian Federation
MD, PhD
56 Dostoevskogo St., Stavropol, 355019, Russian Federation
N. N. Moiseeva
Russian Federation
MD
56 Dostoevskogo St., Stavropol, 355019, Russian Federation
V. S. Odinets
Russian Federation
MD, PhD, chief physician
56 Dostoevskogo St., Stavropol, 355019, Russian Federation
References
1. Raviglione MC, Korobitsyn AA. End TB – the new WHO strategy in the SDG era, and the contributions from the Russian Federation. Tuberculosis and Lung Diseases. 2016;94(11):7–15 (In Russ).
2. Guidelines on the management of latent tuberculosis infection. WHO; 2015 (In Russ). URL: https://www.who.int/tb/publications/ltbi_document_page/ru (Accessed 18 December 2020).
3. Federal clinical guidelines for diagnosis and latent tuberculosis infection in children. Moscow: Human Health; 2015 (In Russ).
4. Аksenova VA, Klevno NI, Kazakov AV, Gordina AV, Fatykhova RK. Preventive chemotherapy in children exposed to multiple drug resistant tuberculosis. Tuberculosis and Lung Diseases. 2019;97(6):36–43 (In Russ).
5. Baronova OD, Aksenova VA, Klevno NI, Odinets VS. Latent tuberculosis infection among university students. Tuberculosis and Lung Diseases. 2020;98(3):27–31 (In Russ).
6. Poddubnaya LV, Panina TA, Bardin VI. A preventive treatment of children and adolescent with a high risk for tubercuiosis. Bulletin of Sibirian Medicine. 2013;12(1):133–5 (In Russ).
7. Kudlay D.A. Biomarkers and immunological tests. Experimental and clinical parallels of latent tuberculosis infection. Tuberculosis and Lung Diseases. 2020;98(8):63–74 (In Russ).
8. Kaminsky GD, Kudlay DA, Panova AE, Parolina LE, Peregudova AB, Pshenichnaya NY, et al. Medical tactics in the detection, diagnosis and prevention of co-infection with HIV and tuberculosis. A practical guide. Moscow; 2020 (In Russ). URL: https://www.rosmedlib.ru/book/ISBN9785970457207.html (Accessed 18 December 2020).
9. КKudlay DA, Starshinova AA, Dovgalyuk IF. Recombinant tuberculosis allergen: 10 years of experience with the test in children and adolescents in the Russian Federation (meta-analysis data). Pediatria na GN Speransky. 2020; 99(3):121–9 (In Russ).
Review
For citations:
Baronova O.D., Moiseeva N.N., Odinets V.S. Monitoring of preventive treatment of children having latent tuberculosis infection. Pacific Medical Journal. 2021;(2):43-46. (In Russ.) https://doi.org/10.34215/1609-1175-2021-2-43-46